Signaling T-cell survival and death by IL-2 and IL-15

被引:45
作者
Zambricki, E
Shigeoka, A
Kishimoto, H
Sprent, J
Burakoff, S
Carpenter, C
Milford, E
McKay, D [1 ]
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] NYU, Sch Med, Skirball Inst Biomol Med, Dept Med, New York, NY USA
[3] NYU, Sch Med, Skirball Inst Biomol Med, Dept Pediat, New York, NY USA
[4] NYU, Sch Med, Skirball Inst Biomol Med, Dept Pathol, New York, NY USA
[5] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Nephrol, Boston, MA 02115 USA
关键词
cytokines; cytokine receptors; signal transduction; T cells; transplantation;
D O I
10.1111/j.1600-6143.2005.01075.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Interleukin 2 (IL-2) and interleukin 15 (IL-15) bind to common T-cell surface receptors comprised of unique alpha (IL-2R alpha or IL-15R alpha) and shared beta/gamma chain subunits. Ligation of this receptor by IL-2 can lead to apoptosis whereas IL-15 ligation favors cell survival. Our study examined intra-cellular signaling events associated with IL-2- and IL-15-induced apoptosis and survival in human T cells. We found IL-2 and IL-15 could both induce apoptosis and survival; the outcome depended on cytokine concentration. No qualitative differences in Jak/Stat, Ras/MAPK or PI3K/AKT signaling were seen over a wide range of IL-2 and IL-15 concentrations. These findings suggest that, like T-cell receptor signaling, IL-2R beta/gamma chain signaling is regulated, or "tuned," by the concentration of cytokine.
引用
收藏
页码:2623 / 2631
页数:9
相关论文
共 50 条
  • [31] Thymic Epithelial Cell-Derived IL-15 and IL-15 Receptor α Chain Foster Local Environment for Type 1 Innate Like T Cell Development
    Tao, Huishan
    Li, Lei
    Liao, Nan-Shih
    Schluns, Kimberly S.
    Luckhart, Shirley
    Sleasman, John W.
    Zhong, Xiao-Ping
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [32] Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model
    Berger, Alexandra
    Colpitts, Sarah J.
    Seabrook, Melanie S. S.
    Furlonger, Caren L.
    Bendix, Maura B.
    Moreau, Joshua M.
    McKillop, William M.
    Medin, Jeffrey A.
    Paige, Christopher J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [33] IL-15/IL-15 receptor biology: A guided tour through an expanding universe
    Budagian, Vadirn
    Bulanova, Elena
    Paus, Ralf
    Bulfone-Paus, Silvia
    CYTOKINE & GROWTH FACTOR REVIEWS, 2006, 17 (04) : 259 - 280
  • [34] IL-2 and IL-15 drive intrathymic development of distinct periphery-seeding CD4+Foxp3+ regulatory T lymphocytes
    Apert, Cecile
    Galindo-Albarran, Ariel O.
    Castan, Sarah
    Detraves, Claire
    Michaud, Heloise
    McJannett, Nicola
    Haegeman, Bart
    Fillatreau, Simon
    Malissen, Bernard
    Hollander, Georg
    Zuklys, Saulius
    Santamaria, Jeremy C.
    Joffre, Olivier P.
    Romagnoli, Paola
    van Meerwijk, Joost P. M.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [35] An activation-induced IL-15 isoform is a natural antagonist for IL-15 function
    Zhao, Lei
    Hu, Bo
    Zhang, Yinsheng
    Song, Yuan
    Lin, Dandan
    Liu, Yonghao
    Mei, Yu
    Sandikin, Dedy
    Sun, Weiping
    Zhuang, Min
    Liu, Haiyan
    SCIENTIFIC REPORTS, 2016, 6
  • [36] IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors
    Whitehouse, Gavin
    Gray, Elizabeth
    Mastoridis, Sotiris
    Merritt, Elliot
    Kodela, Elisavet
    Yang, Jennie H. M.
    Danger, Richard
    Mairal, Marta
    Christakoudi, Sofia
    Lozano, Juan J.
    Macdougall, Iain C.
    Tree, Timothy I. M.
    Sanchez-Fueyo, Alberto
    Martinez-Llordella, Marc
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (27) : 7083 - 7088
  • [37] Distinctions in lymphocyte responses to IL-2 and IL-15 reflect differential ligand binding interactions with the IL-2Rβ chain and suggest differential roles for the IL-2Rα and IL-15Rα subunits
    de Jong, JLO
    Farner, NL
    Sondel, PM
    CYTOKINE, 1998, 10 (12) : 920 - 930
  • [38] Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy
    Ma, Shoubao
    Caligiuri, Michael A.
    Yu, Jianhua
    TRENDS IN IMMUNOLOGY, 2022, 43 (10) : 833 - 847
  • [39] Interleukin (IL)-2 and IL-15 have different effects on human natural killer lymphocytes
    Pillet, Anne-Helene
    Theze, Jacques
    Rose, Thierry
    HUMAN IMMUNOLOGY, 2011, 72 (11) : 1013 - 1017
  • [40] Mystery Solved: IL-15
    Fehniger, Todd A.
    JOURNAL OF IMMUNOLOGY, 2019, 202 (11) : 3125 - 3126